What Is an Endotoxin Test in Peptides

An endotoxin test measures the concentration of bacterial lipopolysaccharides (LPS) in a peptide sample. LPS are fragments of the outer membrane of gram-negative bacteria: they are not living cells, they survive heat sterilization intact, and in cell-based experiments they activate immune pathways in ways that can be mistaken for the peptide under study. A compound with 99% HPLC purity can carry significant endotoxin contamination at the same time. The two measurements describe different things, and both matter for research use.

Why HPLC Purity Is Not Enough

High-performance liquid chromatography measures what fraction of total mass corresponds to the target peptide. It separates and quantifies organic impurities with similar chemical properties: deletion sequences, aggregates, synthesis reagent residues. What HPLC does not detect are LPS, which are large lipid-polysaccharide structures present at nanogram-per-milligram concentrations — below the detection threshold of the chromatographic method.

In cell-based research, uncontrolled LPS contamination can:

• Activate TLR4 receptors on cell lines and generate an inflammatory signal the researcher attributes to the peptide.
• Suppress proliferation in sensitive cultures.
• Invalidate cytokine readouts entirely, particularly in experiments designed to measure an anti-inflammatory effect.

That is why suppliers serving laboratories report endotoxin results separately, in the same certificate of analysis that carries the HPLC purity. PeptoClinic's quality documentation publishes both figures for tested lots. One without the other is an incomplete picture of the material.

How the LAL Assay Works

The standard method is the LAL assay (Limulus Amebocyte Lysate). The reagent is derived from the hemolymph of the horseshoe crab (*Limulus polyphemus*): its amebocytes clot in the presence of trace LPS, and that reaction is the basis of detection.

Three formats of the LAL assay exist:

• Gel-clot: the reagent either gels or it does not. Result is qualitative.
• Turbidimetric: measures increasing absorbance as the clot forms. Quantitative.
• Chromogenic: LPS activates an enzyme cascade that releases a yellow dye, measured by absorbance. This is the most sensitive format and the most widely used in quality control for synthetic peptides.

Results are always reported in EU/mg (endotoxin units per milligram of peptide) or in EU/mL when the sample is in solution. The unit is standardized against the FDA Reference Standard Endotoxin, which means EU/mg values from different laboratories are in principle comparable — with important caveats discussed below.

A growing alternative is the rFC assay (recombinant Factor C): it replaces the horseshoe crab with a recombinant protein engineered to perform the same detection step, eliminating the batch-to-batch biological variability inherent in an animal-derived reagent. The European Pharmacopoeia accepted rFC as a valid method in 2021. For synthetic peptides, the two methods are comparable in sensitivity.

Reading the Result on a COA

Research peptide documentation can present endotoxin data in three ways:

• "Endotoxin content: X EU/mg" — exact numeric result.
• "Bacterial endotoxins: less than X EU/mg" — upper bound; the actual value is below it.
• "LAL test: pass / fail" — indicates only whether the lot cleared a predefined threshold.

The numeric value is more useful than a pass/fail because it enables comparison across lots and across suppliers. A "pass" with no declared limit is not comparable to anything: its meaning depends entirely on what threshold the laboratory set, and that information is often absent from the document.

Thresholds commonly cited in experimental literature:

• Less than 1 EU/mg for general cell-based assays.
• Less than 0.5 EU/mg for immune-activation experiments.
• Less than 0.1 EU/mg when working with cells that highly express TLR4.

These are not regulatory requirements for research material. They are conventions drawn from experimental literature and from USP General Chapter 85. Each research group adopts or adjusts them based on the specific assay design. A threshold that is strict enough for a cytokine release study may be more conservative than necessary for a wound-healing model — the biology of the experiment sets the bar, not a universal standard.

Assay Limitations and Interferences

The chromogenic LAL assay has two practical limitations worth knowing before relying on a COA result.

Matrix interference. Certain peptides, at high concentrations, absorb at the same wavelength as the assay dye or inhibit the enzyme cascade. A rigorous COA reports an inhibition/enhancement control — a spike of known LPS added to the sample to verify that the reaction runs as expected within an accepted recovery range. Without that control, a negative result may be a false negative. The COA should state whether the control was performed and whether it passed.

Protocol sensitivity. The laboratory selects the working dilution of the sample, and that choice affects the limit of quantification reported. Two laboratories analyzing the same lot at different dilutions can report different values without either being wrong. The method declared on the COA — gel-clot, turbidimetric, or chromogenic — also matters when comparing results across documents. A gel-clot "pass at 0.25 EU/mL" and a chromogenic "0.08 EU/mg" are not directly comparable without knowing the sample concentration and dilution used for each.

What to Check When a Batch Arrives

When research material is received, the minimum verification is:

• Confirm the COA includes an endotoxin result, not only HPLC purity.
• Confirm the value is in EU/mg and that the method is stated.
• Check whether an inhibition/enhancement control was run and passed.
• Compare the result against the threshold appropriate for the intended experiment.
• Verify that the lot number on the COA matches the lot number printed on the vial label.

A COA with no lot number, or with a lot number that does not match the vial, does not document the material in hand. It may correspond to a prior production run or to a product specification rather than to an analysis of the specific batch shipped.

For researchers working with BPC-157 or TB-500 in cell-based systems, endotoxin control is particularly relevant: both compounds are studied in contexts where a spurious LPS signal could be attributed to the peptide under investigation. The compounds in PeptoClinic's catalog ship with batch documentation, and analytical data available for each lot are provided at the time of quotation.

Laboratory Research Use Only

PeptoClinic supplies peptides strictly for in vitro and laboratory research (Research Use Only).

No material in the catalog is approved or suitable for human or veterinary use, consumption, diagnosis, or treatment. No evaluation has been performed by the FDA, ANMAT, or any equivalent authority. References to endotoxin values, assay methods, and literature thresholds on this page are informational in the context of scientific research only.

Shipping documentation and customs framing for each destination are described in the shipments section of this site.